OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with Mepolizumab
Diego Bagnasco, Benedetta Bondi, Marco Caminati, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 960-960
Open Access | Times Cited: 7
Diego Bagnasco, Benedetta Bondi, Marco Caminati, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 960-960
Open Access | Times Cited: 7
Showing 7 citing articles:
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab
Diego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 43-43
Open Access | Times Cited: 1
Diego Bagnasco, Benedetta Bondi, Luisa Brussino, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 43-43
Open Access | Times Cited: 1
Background therapy in severe asthma on monoclonal antibody treatment in real life
Filippo Cosini, Diego Bagnasco, Fulvio Braido, et al.
Respiratory Medicine (2025) Vol. 237, pp. 107944-107944
Closed Access
Filippo Cosini, Diego Bagnasco, Fulvio Braido, et al.
Respiratory Medicine (2025) Vol. 237, pp. 107944-107944
Closed Access
Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retrospective analysis
Wendy C. Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
Journal of Asthma (2025), pp. 1-14
Open Access
Wendy C. Moore, Alexandra Stach-Klysh, Thomas Corbridge, et al.
Journal of Asthma (2025), pp. 1-14
Open Access
An evaluation of mepolizumab as an add-on maintenance treatment for severe eosinophilic asthma
Zheng Zhu, Xiaoying Chen, Yiting Luo, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access
Zheng Zhu, Xiaoying Chen, Yiting Luo, et al.
Expert Opinion on Biological Therapy (2025)
Closed Access
Clinical Remission of Mild-to-Moderate Asthma: Rates, Contributing Factors, and Stability
Mana Ishizuka, Naoya Sugimoto, Konomi Kobayashi, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100431-100431
Open Access
Mana Ishizuka, Naoya Sugimoto, Konomi Kobayashi, et al.
Journal of Allergy and Clinical Immunology Global (2025), pp. 100431-100431
Open Access
Time is lung: Higher preservation of lung function in severe asthma patients after earlier mepolizumab treatment
Francisco Javier González‐Barcala, Irina Bobolea, Javier Domínguez‐Ortega, et al.
ERJ Open Research (2024) Vol. 11, Iss. 1, pp. 00211-2024
Open Access | Times Cited: 1
Francisco Javier González‐Barcala, Irina Bobolea, Javier Domínguez‐Ortega, et al.
ERJ Open Research (2024) Vol. 11, Iss. 1, pp. 00211-2024
Open Access | Times Cited: 1
Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
World Allergy Organization Journal (2024) Vol. 18, Iss. 1, pp. 101016-101016
Open Access
Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
World Allergy Organization Journal (2024) Vol. 18, Iss. 1, pp. 101016-101016
Open Access
